Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Mesothelioma, Malignant 4Unspecified Adult Solid Tumor, Protocol Specific 3Lung Neoplasms 3Wilms Tumor 2Mesothelioma 2Kidney Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Non-Small-Cell Lung 2Unspecified Childhood Solid Tumor, Protocol Specific 1Solid Tumor 1Small Cell Lung Carcinoma 1Sarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Pancreatic Neoplasms 1Optic Nerve Glioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms 1Myelodysplastic Syndromes 1Medulloblastoma 1Liver Neoplasms 1Leukemia 1Hepatoblastoma 1Familial ependymoma 1Congenital Abnormalities 1Colorectal Neoplasms 1Colonic Neoplasms 1Central Nervous System Neoplasms 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Filgrastim 3Etoposide 3Ifosfamide 2Granulocyte Colony-Stimulating Factor 2Carboplatin 2Busulfan 2sargramostim 1becatecarin 1alvocidib 1Thrombopoietin 1Thiotepa 1Tamoxifen 1Stem Cell Transplantation 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Peripheral Blood Stem Cell Transplantation 1Mesna 1Melphalan 1Immunologic Techniques 1Doxorubicin 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Optic Nerve Glioma × sargramostim × Other solid neoplasm × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡